Deborah Palestrant is a partner at 5AM Ventures and executive chair of its 4:59 company-building initiative. She previously led corporate development and strategy at Relay Therapeutics, worked in business development and strategy at Editas Medicine and helped launch Blueprint Medicines and Editas while at Third Rock Ventures. Earlier, she led a drug-discovery lab at Novartis. She also serves as a board member and treasurer of the New England Venture Capital Association.
Deborah Palestrant is a partner at 5AM Ventures and executive chair of its 4:59 company-building initiative. She previously led corporate development and strategy at Relay Therapeutics, worked in business development and strategy at Editas Medicine and helped launch Blueprint Medicines and Editas while at Third Rock Ventures. Earlier, she led a drug-discovery lab at Novartis. She also serves as a board member and treasurer of the New England Venture Capital Association.
Career
Partner and Executive Chair of 4:59 Initiative at 5AM Ventures until Present